MIA ALBANESE: Open Payments
NPI 1912690371 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 81 payments from 20 companies in 2025. Trend: 2023 $185 · 2024 $419 · 2025 $1,539
Food & beverage: $1,324Education: $216
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $252 |
| Regeneron Healthcare Solutions, Inc. | 6 | $170 |
| ABBVIE INC. | 19 | $169 |
| Galderma Laboratories, L.P. | 6 | $148 |
| LEO Pharma Inc. | 8 | $126 |
| UCB, Inc. | 7 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $119 |
| Janssen Biotech, Inc. | 4 | $65 |
| Lilly USA, LLC | 3 | $64 |
| Amgen Inc. | 2 | $41 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, Rhapsido, Bimzelx, COSENTYX, ADBRY, TREMFYA.
Industry payments across PA — which companies pay providers there.
